Breaking News on Supplements & Nutrition - North AmericaEU edition

Ingredients > Vitamins & premixes

News headlines

Edison Pharma signs licensing agreement with Japanese pharma giant for alpha-tocotrienol quinone development

Mountain View, California based Edison Pharmaceuticals has announced a licensing agreement with Dainippon Sumitomo Pharma Co., Ltd to develop and commercialize EPI-743 for mitochondrial function and aging. EPI-743 is the quinone form of alpha tocotrienol.

Vitamin K2 shows ‘extremely important improvements in clinical outcomes’ for bone health

Supplements containing vitamin K2 may reduce bone loss and improve bone impact strength in postmenopausal women, according to a new ‘ground-breaking’ study sponsored by NattoPharma.

Vitamin D supplements may yield immune benefits in healthy people: Study

Improving levels of vitamin D in the blood via supplementation could help to fight of disease by affecting gene expression and boosting the immune system, say researchers.

Brazil continues to dominate South American health & wellness market

The Brazilian functional and fortified packaged foods and dietary supplements markets have hit almost US$10 billion, says data from Euromonitor International.

Maternal vitamin D has no effect on children's bone health

Supplementation with vitamin D during pregnancy has no significant association with children's later bone heath, according o the largest ever study on maternal vitamin D supplementation.

Will vitamin C price fixing victory constrain future Chinese cartel behavior?

A longstanding vitamin C price fixing case has reached conclusion with a $162 million judgment in the case involving four Chinese companies. While its a victory for the concept of private enforcement, it doesn’t mean cartel behavior by Chinese companies is necessarily a thing of the past, observers say.

Special edition: Antioxidants and carotenoids

Antioxidants and Pro-oxidants: Two Sides of the Same Sword

Heads or tails, the yin and the yang – there are two sides to everything, and the same can be said for the ‘antioxidant’ debate. In this guest article, Steve Baugh, Technical Services Director of ChromaDex Analytics Inc, gives us his views on antioxidants and pro-oxidants, and the potential rise of a new field of applied redox medicine.

Special edition: Antioxidants & carotenoids

Prof Blumberg: We need reference intakes for phytochemicals (and we’re not calling them antioxidants)

Establishing some kind of intake recommendations for polyphenols and carotenoids will spur innovation and allow for rational synergies of phytochemicals with specific health outcomes, says Prof Jeffrey Blumberg from Tufts University.

High-dose vitamins and minerals offer no benefit for recurrent 'cardiac events'

Supplementation with vitamins and minerals does not help to reduce recurrences of cardiac events in people who have suffered a heart attack, says research.

Chromadex cements position in NR market with third IP acquisition

Chromadex has announced a licensing deal with Washington University in St. Louis for the worldwide exclusive patent rights related to the recently discovered vitamin nicotinamide riboside (NR). It is Chromadex’s third IP acquisition related to the molecule.

Do vitamin D levels influence genes for immune health?

Blood levels of vitamin D may affect the expression of genes linked to immune health and inflammation, Norwegian scientists report for the first time.

Folate and vitamin B12 backed to help battle schizophrenia symptoms

Adding vitamin supplements to antipsychotic medication may help to alleviate certain negative symptoms in people who suffer from schizophrenia, researchers suggest.

Vitamin D pills linked to better heart health for diabetics

Supplements of vitamin D may improve cardiovascular health for diabetics, says a new study with implications for recommended doses in diabetics.

Nicole Kidman and a focus on research & quality: Swisse Wellness outlines strategy behind ambitious US expansion

Swisse Wellness – Australia’s #1 multivitamin brand – is hitting US mass retail with 15 of its top-selling products available in Walgreens, and aims of $0.5 billion in sales by 2015.

Excess vitamin D in pregnancy may lead to food allergies: Study

Consumption of high doses of vitamin D supplements during pregnancy may raise the risk of children developing food allergies after birth, says research.

Nestlé buys Louisiana depression food firm

Nestlé has bought its second brain health-focused medical foods start-up in eight months after snaffling Red River Pharma-owned Pamlab which makes high-dose vitamin supplements targeting depression, diabetes and Alzheimer’s.

MLM model increases meal replacement compliance, Qivana's new chief science officer says

Donald Layman has taken on the position of chief scientific officer with Provo, UT-based supplment manufacturer Qivana, cementing a relationship that began when the company developed a line of meal replacements and supplements based on his nutritional discoveries.

Nutrition 2.0: ‘Closer than you think’ and a ‘tremendous technical and business opportunity’

‘Tremendous opportunities’ await the nutrition industry as it embarks upon a modernized scientific approach to address nutrition, health/wellness and aging, says the Chief Executive Officer of a Silicon Valley company at the cutting edge of R&D.

NPA, CRN: USPSTF’s vitamin D, calcium advice could be harmful to women at risk of fractures

Controversial new recommendations from the U.S. Preventive Services Task Force (USPSTF) for vitamin D and calcium could create confusion among consumers and ‘compromise their bone health’, say the Council for Responsible Nutrition (CRN) and the Natural Products Association (NPA).

Could multivitamins boost well-being and energy levels?

Daily consumption of a multivitamin may boost consumers’ perception of mood and energy levels, says a new study from Australia.